Working towards meaningful innovation

Join with us as Dr Anand Gautam shares his story, including  academia versus industry and research translation in Australia & Pfizer. Dr  Gautam has had wide-ranging leadership roles in R&D and innovation strategies in Inflammation/Autoimmune Diseases/Cancer at international biotech and pharmaceutical companies for over 30 years. Anand has spent over 12 years as an academic in Immunology in prestigious research centres in the UK (PhD at University of London), US (post-doc at Stanford University, California), and Australia (Academic positions at ANU, Canberra  & UQ, Brisbane). Before joining Pfizer as a Head of External Science & Innovation, ANZ & Southeast Asia in April 2017, Anand was a Senior Director of R&D Innovation Sourcing at Novo Nordisk, Copenhagen for eight years. Prior to that, Anand was VP of R&D at Progen (Brisbane, Australia), and SVP of External Science & Collaboration at Pharmexa (Denmark). Dr Gautam has obtained numerous grants to carry out his scientific research, including an NIH gran; a Career Development Award from Juvenile Diabetes Foundation International, USA; and a Howard Florey Young Investigator’s Award from the ANU, Canberra.   Anand serves on number committees (e.g. AusBiotech and Bridge Program at MTPconnect, Australia), is a Life Science Queensland Ambassador, and is an Adjunct Professor at The Institute for Molecular Biosciences, The University of Queensland.

Dr Anand Gautam

Senior Director and Head of External Science & Innovation (ES&I), Pfizer

No recording available due to commercial confidentiality.